| Descriptor English: | Sneddon Syndrome | ||||||
| Descriptor Spanish: |
Síndrome de Sneddon
| ||||||
| Descriptor Portuguese: | Síndrome de Sneddon | ||||||
| Descriptor French: | Syndrome de Sneddon | ||||||
| Entry term(s): |
Livedo Reticularis And Cerebrovascular Accidents Livedo Reticularis, Systemic Involvement Sneddon Champion Syndrome Sneddon-Champion Syndrome Syndrome, Sneddon Syndrome, Sneddon-Champion |
||||||
| Tree number(s): |
C10.228.140.300.750 C14.907.253.774 C17.800.862.775 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D018860 | ||||||
| Scope note: | A systemic non-inflammatory arteriopathy primarily of middle-aged females characterized by the association of LIVEDO RETICULARIS, multiple thrombotic CEREBRAL INFARCTION; CORONARY DISEASE, and HYPERTENSION. Elevation of antiphospholipid antibody titers (see also ANTIPHOSPHOLIPID SYNDROME), cardiac valvulopathy, ISCHEMIC ATTACK, TRANSIENT; SEIZURES; DEMENTIA; and chronic ischemia of the extremities may also occur. Pathologic examination of affected arteries reveals non-inflammatory adventitial fibrosis, thrombosis, and changes in the media (From Jablonski, Dictionary of Syndromes & Eponymic Diseases, 2d ed; Adams et al., Principles of Neurology, 6th ed, p861; Arch Neurol 1997 Jan;54(1):53-60). Mutations in the CECR1 gene (ADA2 protein, human) are associated with Sneddon syndrome. |
||||||
| Annotation: | do not confuse with SNEDDON-WILKINSON DISEASE see SKIN DISEASES, VESICULOBULLOUS |
||||||
| Allowable Qualifiers: |
BL blood CF cerebrospinal fluid CI chemically induced CL classification CN congenital CO complications DG diagnostic imaging DH diet therapy DI diagnosis DT drug therapy EC economics EH ethnology EM embryology EN enzymology EP epidemiology ET etiology GE genetics HI history IM immunology ME metabolism MI microbiology MO mortality NU nursing PA pathology PC prevention & control PP physiopathology PS parasitology PX psychology RH rehabilitation RT radiotherapy SU surgery TH therapy UR urine VE veterinary VI virology |
||||||
| Previous Indexing: |
Cerebrovascular Disorders (1983-1995) Skin (1979-1983) Skin Diseases, Vascular (1993-1995) |
||||||
| Public MeSH Note: | 1996 |
||||||
| History Note: | 1996 |
||||||
| DeCS ID: | 32608 | ||||||
| Unique ID: | D018860 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 1996/01/01 | ||||||
| Date of Entry: | 1994/12/27 | ||||||
| Revision Date: | 2012/07/03 |
|
|
Sneddon Syndrome
- Preferred
| Concept UI |
M0028214 |
| Scope note | A systemic non-inflammatory arteriopathy primarily of middle-aged females characterized by the association of LIVEDO RETICULARIS, multiple thrombotic CEREBRAL INFARCTION; CORONARY DISEASE, and HYPERTENSION. Elevation of antiphospholipid antibody titers (see also ANTIPHOSPHOLIPID SYNDROME), cardiac valvulopathy, ISCHEMIC ATTACK, TRANSIENT; SEIZURES; DEMENTIA; and chronic ischemia of the extremities may also occur. Pathologic examination of affected arteries reveals non-inflammatory adventitial fibrosis, thrombosis, and changes in the media (From Jablonski, Dictionary of Syndromes & Eponymic Diseases, 2d ed; Adams et al., Principles of Neurology, 6th ed, p861; Arch Neurol 1997 Jan;54(1):53-60). Mutations in the CECR1 gene (ADA2 protein, human) are associated with Sneddon syndrome. |
| Preferred term | Sneddon Syndrome |
| Entry term(s) |
Livedo Reticularis And Cerebrovascular Accidents Livedo Reticularis, Systemic Involvement Sneddon Champion Syndrome Sneddon-Champion Syndrome Syndrome, Sneddon Syndrome, Sneddon-Champion |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
